• Proactive interview with Inflection Biosciences CEO, Darren Cunningham, during the BIO CEO & Investor Conference, NYC, February 2020.
   

• SiliconRepublic interview with Inflection Biosciences CEO, Darren Cunningham, as part of European Biotech Week - September 2017.

​

• Pharmaboardroom.com interview with Inflection Biosciences CEO, Darren Cunningham, as part of their Country Report on Ireland - November 2016.

​

• ecancertv: Dr. Giles Best, Kolling Institute of Medical Research, University of Sydney, discusses the potential for IBL-202 in chronic lymphocytic leukaemia (CLL) - September 2015.
   

• Business Plus: Feature on Inflection Biosciences - December 2014.
   

• BioCentury: Emerging Company Profile - Pairing up PIM - July 29, 2013.

​

• 'Drug Discovery with Strong Inflection'; DDN News - July 2013.

​

• The Sunday Business Post 'Start up of the Day': Inflection Biosciences - July 5, 2013.

​

• The Sunday Business Post Done Deal: Inflection Biosciences - June 9, 2013.

​

• The Irish Independent: Inflection Biosciences- June 4, 2013.

​

• Darren Cunningham, CEO of Inflection Biosciences, interviewed on Morning Ireland Radio in connection with Inflection Biosciences’ license agreement with CNIO - June 4, 2013.

​

• Darren Cunningham, CEO of Inflection Biosciences, interviewed on national television in connection with Inflection Biosciences’ license agreement with CNIO – June 4, 2013.